A Promising Tropical Medicinal Plant: Taiwan as the Production Hub of Japan's Coca Empire

Before World War II, Taiwan became the second‐largest coca leaf production base in Asia, second only to Java, contributing to Japan's position as the world's largest exporter of cocaine. While Japan's opium empire has been the subject of extensive academic inquiry, its coca empire has...

Full description

Saved in:
Bibliographic Details
Published inBerichte zur Wissenschaftsgeschichte Vol. 47; no. 4; pp. 352 - 381
Main Author Lu, Shao‐li
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 01.12.2024
Subjects
Online AccessGet full text
ISSN0170-6233
1522-2365
1522-2365
DOI10.1002/bewi.202400005

Cover

More Information
Summary:Before World War II, Taiwan became the second‐largest coca leaf production base in Asia, second only to Java, contributing to Japan's position as the world's largest exporter of cocaine. While Japan's opium empire has been the subject of extensive academic inquiry, its coca empire has received far less attention. This article explores Taiwan's role in Japan's dual empire of opium and coca, focusing on the environmental and historical factors that enabled the island to rapidly expand coca production. It finds that, in addition to Taiwan's favorable climate for coca cultivation, the island's long‐established tea industry provided mature techniques for harvesting and drying the coca leaves. Furthermore, the sugar company supplied the necessary equipment and capital for the extraction of cocaine, becoming a key resource in the industry's development. Learning from the limitations of the opium monopoly—where raw materials were increasingly constrained by international markets—the colonial government sought to promote self‐sufficiency in coca production. This strategy not only ensured a stable supply of raw materials but also allowed the coca industry to balance for the declining incomes from opium as international controls tightened. From all angles, the coca industry met Japan's expectations as a “promising drug.”
Bibliography:This article is a result of the Taiwan‐Germany collaborative project, “Materialities of Medical Cultures in/between Europe and East Asia,” jointly organized by the Institute of History and Philology at Academia Sinica and TU Braunschweig. The project received funding from the DFG and Taiwan′s National Science and Technology Council (NSTC). I extend my heartfelt gratitude to the project team for their support and insightful suggestions, particularly Bettina Wahrig, Angelika C. Messner, Sean Hsiang‐li Lei, Chang Che‐chia, Lee Jen‐der, and Dominik Merdes.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0170-6233
1522-2365
1522-2365
DOI:10.1002/bewi.202400005